NCT05943912

Brief Summary

The aim of this clinical study is to compare the efficacy of DIMS technology spectacle lenses with conventional single vision spectacle lenses at slowing the progression of myopia in the category of children and young adults during three years.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Apr 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2023Dec 2026

Study Start

First participant enrolled

April 17, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 4, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 13, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2026

Last Updated

April 2, 2024

Status Verified

March 1, 2024

Enrollment Period

3.5 years

First QC Date

July 4, 2023

Last Update Submit

March 29, 2024

Conditions

Keywords

myopiaaxial lengthDIMS

Outcome Measures

Primary Outcomes (1)

  • Axial length of eye

    biometry (Lenstar 900)

    in 36 moths therapy

Secondary Outcomes (1)

  • Objective refraction

    in 36 month therapy

Study Arms (2)

Single Vision Spectacle Lens

Participants who chose to correct myopia with single vision spectacle lenses.

Other: Single Vision Spectacle Lens

Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens

Participants who chose to correct myopia with DIMS spectacle lenses.

Other: Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens

Interventions

36 months of therapy

Single Vision Spectacle Lens

36 months of therapy

Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens

Eligibility Criteria

Age6 Years - 26 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

To evaluate the efficacy of Defocus Incorporated Multiple Segment (DIMS) lenses in slowing myopia progression in a young European population of progressing myopes. A prospective, non-randomized, observational 3 - year study will be conducted in 80 progressing myopes aged 6-26 years, with myopia between -0,25D and -8,5D and astigmatism -0,25 and -2,25DC. Participants self-selected wearing DIMS (n=55) or single vision (SV) lenses (n=25). Spherical Equivalent Refraction (SER, cycloplegic autorefraction) and axial length (AL) were measured at baseline. AL will be measured at 3M, 6M and every 6M and SER will be measured every 12M.

You may qualify if:

  • Progressive myopia
  • Myopes aged 6-26 years
  • Myopia between -0,25D and -8,5D
  • Astigmatism -0,25 and -2,25DC

You may not qualify if:

  • Ocular pathology
  • Amblyopia
  • Strabism
  • Non-compliance to eye examinations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Czech Technical University

Prague, Czech Republic, Czechia

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Marketa Zakova, Ph.D.

    Czech Technical University in Prague

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2023

First Posted

July 13, 2023

Study Start

April 17, 2023

Primary Completion (Estimated)

October 10, 2026

Study Completion (Estimated)

December 12, 2026

Last Updated

April 2, 2024

Record last verified: 2024-03

Locations